In response

Annals of Internal Medicine

Volumn 162, Issue 10, 2015, Pages 735-736

  Collins, Gary S ^a   Reitsma, Johannes B ^b   Altman, Douglas G ^a   Moons, Karel G M ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; TUMOR MARKER;

CARDIOVASCULAR DISEASE; HUMAN; LETTER; LUNG CANCER; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; RISK; DECISION SUPPORT SYSTEM; DIAGNOSIS; STATISTICAL MODEL;

DECISION SUPPORT TECHNIQUES; DIAGNOSIS; HUMANS; MODELS, STATISTICAL; PROGNOSIS;

EID: 84937549517     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/L15-5093-2     Document Type: Letter

References (2)

1. Moons KG, Altman DG, Reitsma JB, Ioannidis JP, Macaskill P, Steyerberg EW, et al. Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med. 2015;162:W1-73. [PMID: 25560730] doi:10.7326/M14-0698
2. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM; Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics. Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst. 2005;97:1180-4. [PMID: 16106022]